In addition, HOTAIRM1 expression was associated with the grade malignancy of brain tumor, and HOTAIRM1 levels of high-grade glioma (WHO III and IV) were significantly higher than low-grade glioma (WHO I and II) (Fig. 1c). This evidence concerns the gene HOTAIRM1 and glioma.